Avidin as part of a European consortium leaded by the Burgos University (Spain) successfully won a H2020 grant (PHC-14-2015) entitled „Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters” (Project acronym: TAT-CF).

The project will develop an innovative therapeutic approach for the treatment of Cystic Fibrosis (CF) by evaluating small molecules capable of facilitating the transmembrane transport of anions such as chloride and bicarbonate and will thus enable CF treatment by replacing the missing CFTR anion permeation activity. This represents an unexplored path in the treatment of CF and a paradigm shift with respect to current strategies searching for a cure for CF.

The 3 years project started on January 1st, 2016.